Table 1. Clinical characteristics of the study participants.
| Clinicopathologic characteristics | HCC | LC | CHB | NC |
|---|---|---|---|---|
| Number of patients | 82 | 29 | 28 | 31 |
| Gender (male/female) | 64/18 | 25/4 | 18/10 | 20/11 |
| Mean age (SD) | 56.78(10.58) | 52.17(13.34) | 38.14(12.10) | 46.30(10.63) |
| Child-Pugh grade (A/B/C) | 71/9/2 | 17/10/2 | 25/2/1 | - |
| Tumor size, cm (≤3/>3) | 26/56 | - | - | - |
| BCLC stage (0/A/B/C/D) | 9/17/34/20/2 | - | - | - |
| AFP, ug/L (≤20/>20) | 45/37 | 19/10 | 25/3 | 31/0 |
| DKK1, ng/L (≤550.93/>550.93) | 9/73 | 11/18 | 14/14 | 21/10 |
| TEMs, % (≤4.95/>4.95) | 23/59 | 19/10 | 20/8 | 23/8 |
HCC, hepatocellular carcinoma; LC, liver cirrhosis; CHB, chronic hepatitis B virus infection; NC, normal controls